(Q43595752)

25 November 2017

title

Targeting of vasculature in cancer and other angiogenic diseases (English)

1 reference

25 November 2017

S Kumar

1

1 reference

25 November 2017

C Li

series ordinal

2

1 reference

25 November 2017

publication date

1 March 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

22

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

129

1 reference

Clinical trials of antibody therapy

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901840-8

7 January 2021

Fighting cancer by attacking its blood supply

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901840-8

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901840-8

7 January 2021

Thalidomide for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901840-8

7 January 2021

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901840-8

7 January 2021

Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogenous expression of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901840-8

7 January 2021

Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901840-8

7 January 2021

Antiangiogenic radioimmunotherapy of human solid tumors in SCID mice using (125)I-labeled anti-endoglin monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901840-8

7 January 2021

Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901840-8

7 January 2021

New discoveries still abundant in monoclonal antibody research

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4906%2800%2901840-8

7 January 2021

10.1016/S1471-4906(00)01840-8

Identifiers

DOI

1 reference

25 November 2017

1 reference